Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Credit agrmnt [a]
AKORN INC (AKRXQ) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/02/2020 8-K Quarterly results
09/30/2020 8-K Quarterly results
08/28/2020 8-K Quarterly results
08/14/2020 8-K Quarterly results
08/07/2020 8-K Quarterly results
07/31/2020 8-K Quarterly results
07/02/2020 8-K Quarterly results
06/18/2020 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Share Purchase Agreement, by and among Akorn, Inc., WorldAkorn Pharma Mauritius, Akorn India Private Limited and Biological E. Limited"
05/26/2020 8-K Entry into a Material Definitive Agreement, Bankruptcy or Receivership, Notice of Delisting or Failure to Satisfy a Continued...
Docs: "Asset Purchase Agreement, by and between the Company Parties and the Buyer",
"Senior Secured Super-Priority Term Loan Debtor-In-Possession Loan Agreement, between the Company Parties and the DIP Lenders, and Wilmington Savings Fund Society, FSB, as Administrative Agent"
05/21/2020 8-K Acquisition/merger/asset purchase announced
Docs: "Restructuring Support Agreement, by and between the Company Parties and Consenting Term Lenders",
"Akorn to Use Voluntary Chapter 11 Process to Position Business for Long-Term Success"
05/11/2020 8-K Quarterly results
Docs: "Akorn Provides First Quarter 2020 Results"
05/01/2020 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
04/22/2020 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
Docs: "Cleansing Materials"
04/01/2020 8-K Quarterly results
04/01/2020 8-K Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arran...
03/13/2020 8-K Quarterly results
03/04/2020 8-K Quarterly results
02/26/2020 8-K Quarterly results
02/12/2020 8-K Quarterly results
02/10/2020 8-K Quarterly results
01/27/2020 8-K Other Events  Interactive Data
12/20/2019 8-K Quarterly results
12/16/2019 8-K Credit agreement amendment
Docs: "Amended Standstill Agreement",
"Form of Recoupment Letter Agreement"
11/25/2019 8-K Other Events  Interactive Data
11/12/2019 8-K Quarterly results
11/12/2019 8-K Quarterly results
11/05/2019 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Akorn to Present at the Credit Suisse Healthcare Conference"
10/31/2019 8-K Quarterly results
09/10/2019 8-K Quarterly results
08/12/2019 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Stipulation and Agreement of Settlement"
08/02/2019 8-K/A Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/01/2019 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Akorn Provides Preliminary Second Quarter 2019 Results"
07/30/2019 8-K Quarterly results
06/25/2019 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Akorn Receives FDA Warning Letter LAKE FOREST, Ill., June 25, 2019 – Akorn, Inc. , a leading specialty generic pharmaceutical company, announced that it received a warning letter from the U.S. Food and Drug Administration related to the inspection of its Somerset, New Jersey manufacturing facility in July and August of 2018. Akorn is committed to the highest standards of quality and compliance, and will continue to work collaboratively with the FDA to resolve all issues addressed in the warning letter. The Company will respond to the FDA letter within the required 15 working days from receipt of the letter. Douglas Boothe, Akorn’ s President and Chief Executive Officer, stated, “Akorn is committed to resolving the warning letter in a comprehensive and effective manner. Earlier this year, A..."
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy